Disease burden and the role of pharmacogenomics in African populations
Global Health, Epidemiology and Genomics · 2017
DOI: 10.1017/gheg.2016.21 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Global Health, Epidemiology and Genomics, 2017. Verfasst von K L Mpye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine, University …. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The burden of communicable and non-communicable diseases in Sub-Saharan Africa poses a challenge in achieving quality healthcare. Although therapeutic drugs have generally improved health, their efficacy differs from individual to individual. Variability in treatment response is mainly because of genetic variants that affect the pharmacokinetics and pharmacodynamics of drugs.
Method
The intersection of disease burden and therapeutic intervention is reviewed, and the status of pharmacogenomics knowledge in African populations is explored.
Results
The most commonly studied variants with pharmacogenomics relevance are discussed, especially in genes coding for enzymes that affect the response to drugs used for HIV, malaria, sickle cell disease and cardiovascular diseases.
Conclusions
The genetically diverse African population is likely to benefit from a pharmacogenomics-based healthcare approach, especially with respect to reduction of drug side effects, and separation of responders and non-responders leading to optimized drug choices and doses for each patient.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa.
- Department of Clinical Pharmacology, College of Health Sciences, University of Zimbabwe, P.O. Box A178, Avondale, Harare, Zimbabwe.
- International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Wernher and Beit Building (South), UCT Campus, Anzio Road, Observatory, 7925, Cape Town, South Africa.
- Division of Medical Biochemistry, Faculty of Health Sciences, University of Cape Town, Observatory, 7925, Cape Town, South Africa.
- Department of Archaeology, University of Cape Town, Cape Town, Rondebosch 7701, South Africa.
Zitieren
APA
Mpye, K. L., Matimba, A., Dzobo, K., Chirikure, S., Wonkam, A., & Dandara, C. (2017). Disease burden and the role of pharmacogenomics in African populations. Global Health, Epidemiology and Genomics. https://doi.org/10.1017/gheg.2016.21
Vancouver
Mpye KL, Matimba A, Dzobo K, Chirikure S, Wonkam A, Dandara C. Disease burden and the role of pharmacogenomics in African populations. Global Health, Epidemiology and Genomics. 2017. doi:10.1017/gheg.2016.21
BibTeX
@article{Mpye2017,
author = {Mpye, K L and Matimba, A and Dzobo, K and Chirikure, S and Wonkam, A and Dandara, C},
title = {Disease burden and the role of pharmacogenomics in African populations},
journal = {Global Health, Epidemiology and Genomics},
year = {2017},
doi = {10.1017/gheg.2016.21}
}
EUVIMED